Omaveloxolone

3 trials 1 recruiting NNeurology/Psychiatry Orphan designation

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

1 Recruiting

1 Completed trials

3 Sponsors

10 Countries

Phase III

Phase II

Phase IV

Phase III: 1 Phase II: 1 Phase IV: 1

Oversight events:

1 unexpected event across 1 trial

View oversight register →

Indications tested

Friedreich's ataxia 2

Sponsors using this IMP

Biogen Idec Research Limited 1 Fakultni Nemocnice V Motole 1 Reata Pharmaceuticals Inc. 1

All trials

3 total

Identification of mitochondrial biomarkers reflecting omaveloxolone treatment (in FA patients) Pending

2025-523881-26-00 Phase IV 2 countries Fakultni Nemocnice V Motole
A Phase 3 study of Omaveloxolone in participants with Friedreich’s Ataxia Ages 2 < 16 years Recruiting

2025-520896-13-00 Phase III 8 countries Biogen Idec Research Limited
A Phase 2 Study of the Safety, Efficacy, and Pharmacodynamics of RTA 408 in the Treatment of Friedreich’s Ataxia Ended

2024-517436-22-00 Phase II 2 countries Reata Pharmaceuticals Inc.

Showing 1–3 of 3 trials

← All drugs A–Z